[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.197.185.157. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Article
January 23, 1995

Aspirin and the Risk of Digestive Cancers-Reply

Author Affiliations

Iowa City, Iowa

Atlanta, Ga

Arch Intern Med. 1995;155(2):214-217. doi:10.1001/archinte.1995.00430020107017
Abstract

In reply

Evidence on the chemopreventive potential of aspirin and other nonaspirin nonsteroidal anti-inflammatory drugs (NSAIDs) against colorectal cancer is based on experimental cancer in rodents, interventional studies in patients with familial adenomatous polyposis, and some, but not all, epidemiologic investigations.1 As NSAID use may result in serious renal and gastrointestinal side effects, particularly in the elderly, recommendations on chemoprevention with NSAIDs and the optimal regimen must await efficacy-to-toxicity and risk-to-benefit analyses in prospective controlled trials.

First Page Preview View Large
First page PDF preview
First page PDF preview
×